journal article·2025-06-20Open access

Fe(III)-Based Nanomicelles for Magnetic Resonance Imaging of Colorectal Cancer with Hepatic Metastasis

Tianlun Shen, Kaiwei Lv, Zhenyan Chen, Songyi Xu, Guangyao Li, Guocan Han, Yì Xiáng J. Wáng, Jun Ling, Jihong Sun

Abstract

Colorectal cancer (CRC) is a leading global malignancy with a poor prognosis in advanced stages. Early and accurate diagnosis remains challenging due to the overlapping of clinical manifestations between early-stage CRC and inflammatory bowel diseases. Although dynamic contrast-enhanced MRI (DCE-MRI) is a critical imaging modality for the diagnosis of CRC and colorectal cancer liver metastasis (CRLM), conventional gadolinium-based contrast agents (GBCAs) have the limitations of rapid clearance and potential toxicity risks. In this study, we report a gadolinium-free T1-weighted nanocontrast agent based on Fe(III)-coordinated poly(α-amino acid)s (Fe@POS) nanomicelles. Fe@POS nanomicelles exhibit a high longitudinal relaxivity (r1 = 5.56 mM−1s−1) and prolonged blood circulation time with selective CRC tumor accumulation via enhanced permeability and retention (EPR) effect. In vivo MRI studies revealed long-period MRI of CRC. In CRLM lesions, normal hepatic tissue demonstrates greater Fe@POS uptake compared to tumor tissue, which enables clear delineation of tumor margins on MRI. Histological and biochemical analysis confirmed the biocompatibility of Fe@POS nanomicelles, with no acute toxicity observed, highlighting their potential as alternatives to GBCAs for clinical diagnostic applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China

MOE Key Laboratory of Macromolecular Synthesis and Functionalisation, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China

Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 999077, China

Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou 310027, China

Cancer Center, Zhejiang University, Hangzhou 310058, China

Funding

National Natural Science Foundation of China · “Pioneer” and “Leading Goose” R&D Program of Zhejiang · Major Program Co-sponsored by Province and Ministry · Fundamental Research Funds for the Central Universities

References (56)

Show source-provided references
1. Cancer Statistics, 202410.3322/caac.21820 ↗
2. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
3. Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 202010.1097/CM9.0000000000001474 ↗
4. Colorectal Cancer Statistics, 202310.3322/caac.21772 ↗
6. Treatments for Colorectal Liver Metastases: A New Focus on a Familiar Concept10.1016/j.critrevonc.2016.11.005 ↗
7. Gadolinium-Based Contrast Agents for Magnetic Resonance Cancer Imaging10.1002/wnan.1198 ↗
8. Molecular Body Imaging: MR imaging, CT, and US. Part I. Principles10.1148/radiol.12102394 ↗
9. Vascular and Hepatic Enhancements at MR Imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the Same Subjects10.1016/j.clinimag.2014.01.001 ↗
10. Association of Gadolinium Based Magnetic Resonance Imaging Contrast Agents and Nephrogenic Systemic Fibrosis10.1016/j.juro.2008.05.005 ↗
11. Gadolinium-Induced Fibrosis10.1146/annurev-med-063014-124936 ↗
12. What Nephrologists Need to Know About Gadolinium10.1038/ncpneph0660 ↗
13. Distinct Coordination Chemistry of Fe(III)-Based MRI Probes10.1021/acs.accounts.2c00102 ↗
14. Fe(Deferasirox)(2): An Iron(III)-Based Magnetic Resonance Imaging T(1) Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics10.1021/jacs.1c04963 ↗
15. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers10.1021/acs.chemrev.8b00363 ↗
16. Comparative Evaluation of Different Oral Iron Salts in the Management of Iron Deficiency Anemia10.1007/s40199-024-00517-y ↗
17. An Evaluation of Ferric Derisomaltose as a Treatment for Anemia10.1080/17474086.2021.1858406 ↗
18. Ferric Carboxymaltose: A Review in Iron Deficiency10.1007/s40265-018-0885-7 ↗
19. First Multiparametric Cardiovascular Magnetic Resonance Study Using Ultrasmall Superparamagnetic Iron Oxide Nanoparticles in a Patient with Acute Myocardial Infarction: New Vistas for the Clinical Application of Ultrasmall Superparamagnetic Iron Oxide10.1161/CIRCULATIONAHA.112.108167 ↗
20. Coordinatively Unsaturated Fe(3+) Based Activatable Probes for Enhanced MRI and Therapy of Tumors10.1002/anie.201904880 ↗
21. Iron–Polyphenol Dendritic Complexes for Regulating Amplification of Phenolic Hydroxyl Groups to Improve Magnetic Resonance Imaging10.1016/j.cej.2023.141322 ↗
22. A pH-Sensitive Coordination Polymer Network-Based Nanoplatform for Magnetic Resonance Imaging-Guided Cancer Chemo-Photothermal Synergistic Therapy10.1016/j.nano.2019.102071 ↗
23. Exploiting Shape, Cellular-Hitchhiking and Antibodies to Target Nanoparticles to Lung Endothelium: Synergy Between Physical, Chemical And Biological Approaches10.1016/j.biomaterials.2015.07.043 ↗
24. A Novel Liposome Surface Modification Agent that Prolongs Blood Circulation and Retains Surface Ligand Reactivity10.1163/092050611X605933 ↗
25. PEGylation of MnO Nanoparticles via Catechol–Mn Chelation to Improving T1-Weighted Magnetic Resonance Imaging Application10.1002/app.42360 ↗
26. Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review10.2147/IJN.S368814 ↗
27. The Tumor EPR Effect for Cancer Drug Delivery: Current Status, Limitations, and Alternatives10.1016/j.addr.2022.114614 ↗
28. Evaluation of the Effect of SMA-Pirarubicin Micelles on Colorectal Cancer Liver Metastases and of Hyperbaric Oxygen in CBA Mice10.1080/10611860701499839 ↗
29. Artificial Polymers Made of Alpha-Amino Acids-Poly(Amino Acid)s, Pseudo-Poly(Amino Acid)s, Poly(Depsipeptide)s, and Pseudo-Proteins10.2174/1381612826666200203122110 ↗
30. Bismuth-Loaded Poly(Alpha-Amino Acid) Nanoparticles for CT and Fluorescence Bimodal Imaging10.1021/acs.biomac.4c01640 ↗
31. Fe(3+)@PDOPA-b-PSar Nanoparticles for Magnetic Resonance Imaging and Cancer Chemotherapy10.2147/IJN.S393846 ↗
32. (Bis)Phosphonic Acid-Functionalized Poly(Ethyleneimine)–Poly(Amido Amine)s for Selective In Vitro Transfection of Osteosarcoma Cells10.1021/acsapm.1c00297 ↗
33. Enzyme-Triggered Orthotopic Network Formation from Poly(Amino Acid) Nanoparticle to Suppress Tumor Growth and Metastases10.1016/j.nantod.2024.102222 ↗
34. Wang, T., Qi, Y., Miyako, E., Bianco, A., and Menard-Moyon, C. (2024). Photocrosslinked Co-Assembled Amino Acid Nanoparticles for Controlled Chemo/Photothermal Combined Anticancer Therapy. Small, 20.10.1002/smll.202403282 ↗
35. Protein-Poly(Amino Acid) Nanocore-Shell Mediated Synthesis of Branched Gold Nanostructures for Computed Tomographic Imaging and Photothermal Therapy of Cancer10.1021/acsami.6b03428 ↗
36. Zhou, Z., Yang, L., Gao, J., and Chen, X. (2019). Structure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging. Adv Mater, 31.10.1002/adma.201804567 ↗
37. Formation of a Tris(Catecholato) Iron(Iii) Complex with a Na-ture-Inspired Cyclic Peptoid Ligand10.1039/D1DT00091H ↗
38. Sever, M.J., and Wilker, J.J. (2004). Visible Absorption Spectra of Metal–Catecholate and Metal–Tironate Complexes. Dalton Trans., 1061–1072.10.1039/B315811J ↗
39. Smart Dual T1 Mri-Optical Imaging Agent Based on a Rhodamine Appended Fe(Iii)-Catecholate Complex10.1039/D0DT02364G ↗
40. Second-Sphere and Outer-Sphere Proton Relaxation of Paramagnetic Complexes: From Epr to Nmrd10.1021/jp9704067 ↗
41. Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery10.7150/thno.17098 ↗
42. Sharifi, M., Cho, W.C., Ansariesfahani, A., Tarharoudi, R., Malekisarvar, H., Sari, S., Bloukh, S.H., Edis, Z., Amin, M., and Gleghorn, J.P. (2022). An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment. Cancers, 14.10.3390/cancers14122868 ↗
43. De Angelis, M.L., Francescangeli, F., Nicolazzo, C., Xhelili, E., La Torre, F., Colace, L., Bruselles, A., Macchia, D., Vitale, S., and Gazzaniga, P. (2022). An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer. Front. Oncol., 12.10.3389/fonc.2022.869485 ↗
44. The Impact of Surgical Extent and Sex on the Hepatic Metastasis of Colon Cancer10.1007/s00595-013-0768-1 ↗
45. Contribution of Kupffer Cells to Liposome Accumulation in the Liver10.1016/j.colsurfb.2017.07.014 ↗
46. The Dose Threshold for Nanoparticle Tumour Delivery10.1038/s41563-020-0755-z ↗
47. Elimination Pathways of Nanoparticles10.1021/acsnano.9b01383 ↗
48. In Vivomicroscopy of Hepatic Metastases: Dynamic Observation of Tumor Cell Invasion and Interaction with Kupffer Cells10.1002/hep.1840210233 ↗
49. A Hepatocyte-Targeting Nanoparticle for Enhanced Hepatobiliary Magnetic Res-onance Imaging10.1038/s41551-022-00975-2 ↗
50. Mn2+-Doped Silica Nanoparticles for Hepatocyte-Targeted Detection of Liver Cancer in T1-Weighted Mri10.1016/j.biomaterials.2013.08.009 ↗
51. Detailed Toxicity Studies of Liposomal Gadolinium-DTPA10.1097/00004424-199111000-00007 ↗
52. Biocompatible and Bioreducible Micelles Fabricated from Novel α-Amino Acid-Based Poly(Disulfide Urethane)s: Design, Synthesis and Triggered Doxorubicin Release10.1039/C5PY00828J ↗
53. Synthesis, Properties and Applications of Biodegradable Polymers Derived from Diols and Dicarboxylic Acids: From Polyesters to Poly(Ester Amide)s10.3390/ijms15057064 ↗
54. (2017). Biological Evaluation of Medical Devices Part 11: Tests for Systemic Toxicity (Standard No. ISO 10993-11:2017).
55. Pham, T.T., Liney, G.P., Wong, K., and Barton, M.B. (2017). Functional MRI for Quantitative Treatment Response Prediction in Locally Advanced Rectal Cancer. Br. J. Radiol., 90.10.1259/bjr.20151078 ↗
56. Van Cutsem, E., Verheul, H., Flamen, P., Rougier, P., Beets-Tan, R., Glynne-Jones, R., and Seufferlein, T. (2016). Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians. Cancers, 8.10.3390/cancers8090081 ↗